Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus

NCT07450716 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07450716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus